| Denzinger, Viola (2020): Hemmung der Glykoprotein (GP) VI-vermittelten Thrombozytenaggregation versus primärer Hämostase durch Ibrutinib und die neuen Btk-Inhibitoren Acalabrutinib, ONO/GS-4059, BGB-3111 und Evobrutinib. Dissertation, LMU München: Faculty of Medicine |
Preview |
PDF
Denzinger_Viola.pdf 2MB |
DOI: 10.5282/edoc.25853
| Item Type: | Theses (Dissertation, LMU Munich) |
|---|---|
| Subjects: | 600 Technology, Medicine 600 Technology, Medicine > 610 Medical sciences and medicine |
| Faculties: | Faculty of Medicine |
| Language: | German |
| Date of oral examination: | 9. January 2020 |
| 1. Referee: | Siess, Wolfgang |
| MD5 Checksum of the PDF-file: | 5ca1e46b7f4ad693f3425c6d82120d48 |
| Signature of the printed copy: | 0700/UMD 19416 |
| ID Code: | 25853 |
| Deposited On: | 22. Jan 2021 15:36 |
| Last Modified: | 22. Jan 2021 15:36 |
Repository Staff Only: item control page
